Repligen

Repligen | Inspiring Advances in Bioprocessing.

Launch date

1981

Employees

501-1000 people

Market cap

Enterprise valuation

CAD10.7b (Public information from Sep 2024)

Waltham Massachusetts (HQ)

http://repligen.com

https://twitter.com/repligen https://www.linkedin.com/company/repligen-corporation

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	366m	671m	802m	639m	627m	709m	824m
% growth	36 %	83 %	20 %	(20 %)	(2 %)	13 %	16 %
EBITDA	69.6m	172m	185m	92.1m	108m	154m	203m
% EBITDA margin	19 %	26 %	23 %	14 %	17 %	22 %	25 %
Profit	59.9m	128m	186m	41.6m	27.3m	67.6m	101m
% profit margin	16 %	19 %	23 %	7 %	4 %	10 %	12 %
EV / revenue	27.2x	21.5x	11.3x	14.7x	13.1x	11.4x	9.7x
EV / EBITDA	143.3x	83.8x	49.1x	101.5x	75.8x	52.4x	39.3x
R&D budget	20.2m	34.3m	43.9m	42.7m	-	-	-
R&D % of revenue	6 %	5 %	5 %	7 %	-	-	-

Date	Investors	Amount	Round
May 1986	N/A	N/A	IPO
Dec 2010	N/A	$1.4m	Grant
Jun 2014	N/A	$4.0m	Post IPO Equity
Apr 2019*	N/A	$175m	Post IPO Equity
Dec 2020*	N/A	$312m	Post IPO Equity
Dec 2023*	N/A	$600m	Post IPO Convertible
Total Funding		CAD1.9m

Tech stackLearn more about the technologies and tools that this company uses.

Tantti Laboratory

ACQUISITION by Repligen Jul 2024

TangenX Technology Corp

ACQUISITION by Repligen Dec 2016

Spectrum Laboratories

ACQUISITION by Repligen Jun 2017

ACQUISITION by Repligen Apr 2016

ACQUISITION by Repligen Sep 2021

Artesyn Biosolutions

ACQUISITION by Repligen Nov 2020

ACQUISITION by Repligen Sep 2023

ACQUISITION by Repligen Jun 2021